Q-Line Biotech (NSE:QLINE) Research & Development: ₹ Mil (TTM As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Research & Development?

Q-Line Biotech NSE:QLINE -5.15% 12 Research & Development is ₹ Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Q-Line Biotech's Research & Development for the six months ended in Mar. 2025 was ₹0 Mil. Q-Line Biotech does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Mar. 2025.

Q-Line Biotech  (NSE:QLINE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Q-Line Biotech Research & Development Related Terms

Q-Line Biotech Research & Development Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Research & Development Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Research & Development
0.00 0.00 0.00

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Research & Development 0.00 0.00 0.00
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹ Mil mean?
Q-Line Biotech (NSE:QLINE) has a Research & Development of ₹ Mil as of Mar. 2025. Research and development expense is the total cost for research and development activities. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Research & Development too high?
Q-Line Biotech's current Research & Development is ₹ Mil. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Research & Development compare to ABT and SYK?
Q-Line Biotech's Research & Development of ₹ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Research & Development is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Research & Development of ₹ Mil. The current Research & Development is ₹ Mil. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Research & Development is ₹ Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price